Lipase < 2.0 x the upper limit of normal and no radiologic or clinical evidence of pancreatitis, within 14 days before the first dose of cabozantinib
Lipase < 2.0 x the upper limit of normal and no radiologic or clinical evidence of pancreatitis within 7 days before the first dose of cabozantinib
Lipase < 2.0 x ULN and no radiologic or clinical evidence of pancreatitis
Obtained within 28 days prior to the first dose of cabozantinib: lipase =< 2.0 x the upper limit of normal and no radiologic or clinical evidence of pancreatitis.
Lipase =< 2.0 x ULN and no radiologic or clinical evidence of pancreatitis
Lipase < 2.0 x the upper limit of normal and no radiologic or clinical evidence of pancreatitis
Lipase < 2.0 x ULN and no radiologic or clinical evidence of pancreatitis
Within 4 days prior to the first dose of cabozantinib: Lipase < 2.0 x ULN and no radiologic or clinical evidence of pancreatitis
Lipase < 2.0 x ULN; no radiologic or clinical evidence of pancreatitis
Lipase < 2.0 x the upper limit of normal and no radiologic or clinical evidence of pancreatitis
Within 7 days before the first dose of cabozantinib: Lipase < 2.0 x the upper limit of normal and no radiologic or clinical evidence of pancreatitis
Lipase < 2.0 x ULN; no radiologic/clinical evidence of pancreatitis
Lipase < 2 X the upper limit of normal (ULN) and no radiologic or clinical evidence of pancreatitis
Lipase =< 2.0 x the upper limit of normal and no radiologic or clinical evidence of pancreatitis
Lipase < 2.0 x the upper limit of normal and no radiologic or clinical evidence of pancreatitis
Lipase < 2.0 x ULN and no radiologic or clinical evidence of pancreatitis
Lipase and amylase =< 2.0 x ULN and no radiologic or clinical evidence of pancreatitis
Lipase < 2.0 x the upper limit of normal and no radiologic or clinical evidence of pancreatitis
Lipase < 2.0 x ULN and no radiologic or clinical evidence of pancreatitis